FDA Grants Fast Review of P G Sex Drug  CHICAGO (Reuters) - Procter   Gamble Co. &lt;A HREF="http://www.investor.reuters.com/FullQuote.aspx?ticker=PG.N target=/stocks/quickinfo/fullquote"&gt;PG.N&lt;/A&gt; said on  Tuesday U.S. regulators have granted priority review for its  experimental drug to treat reduced sex drive in women with  menopause triggered by surgery.